You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 66 No. 4, April 2009 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Original Contribution
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (15)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Amyotrophic Lateral Sclerosis
 •Motor Neuron Disease
 •Neuromuscular diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Amyotrophic Lateral Sclerosis in Sweden, 1991-2005

Fang Fang, MD; Unnur Valdimarsdóttir, PhD; Rino Bellocco, ScD; Lars-Olof Ronnevi, MD, PhD; Pär Sparén, PhD; Katja Fall, MD, PhD; Weimin Ye, MD, PhD

Arch Neurol. 2009;66(4):515-519.

Objectives  To investigate the temporal trend of amyotrophic lateral sclerosis (ALS) incidence in Sweden between January 1, 1991, and December 31, 2005, and to explore incidence variations according to major demographic factors.

Design  Population-based study.

Setting  Academic research.

Participants  All incident cases of ALS identified through the Swedish Inpatient Register between January 1, 1991, and December 31, 2005.

Main Outcome Measure  Age-standardized incidence rates were calculated by applying the observed age-specific incidence rates to the age distribution of the Swedish population in 1991. A linear regression model was used to assess the potential trend of the incidence during calendar years. We also followed up the entire population registered in the 1990 Population and Housing Census for incidence of ALS. Relative risk and 95% confidence interval of ALS associated with demographic variables were estimated using Poisson regression models.

Results  The age-standardized incidence rates increased from 2.32 per 100 000 person-years in 1991-1993 to 2.98 per 100 000 person-years in 2003-2005, representing an annual increase of approximately 2% during the 15 years (P value for trend, .002). The age-specific incidence rates increased in all age groups except those younger than 50 years. The observed increase remained significant when restricting the analysis to individuals born in Sweden (P value for trend, <.001). Compared with individuals born from April through June, those born from October through December were at 11% increased risk of ALS (95% confidence interval, 1.01-1.23).

Conclusions  The incidence of ALS has been increasing during the last 15 years in Sweden. Further studies are warranted to explore the underlying reasons for this observed trend.


Author Affiliations: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (Drs Fang, Valdimarsdóttir, Bellocco, Sparén, Fall, and Ye); Centre for Public Health Sciences, University of Iceland, Reykjavík (Dr Valdimarsdóttir); Department of Statistics, University of Milano-Bicocca, Milan, Italy (Dr Bellocco); Department of Neurology, Karolinska Hospital, Stockholm, Sweden (Dr Ronnevi); and Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts (Dr Fall).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

This Month in Archives of Neurology
Arch Neurol. 2009;66(4):431-432.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis
Byrne et al.
J. Neurol. Neurosurg. Psychiatry 2011;82:623-627.
ABSTRACT | FULL TEXT  

Statin Use and Risk of Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders
Sorensen et al.
Circ Cardiovasc Qual Outcomes 2010;3:413-417.
ABSTRACT | FULL TEXT  

From the Cover: Transfer of a cyanobacterial neurotoxin within a temperate aquatic ecosystem suggests pathways for human exposure
Jonasson et al.
Proc. Natl. Acad. Sci. USA 2010;107:9252-9257.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.